Human umbilical cord blood-derived stromal cells: A new resource for the proliferation and apoptosis of myeloma cells

Hematology

Volumn 19, Issue 3, 2014, Pages 148-157

  Gao, Li ^a   Zhang, Cheng ^a   Zhang, Xi ^a   Gao, Lei ^a   Hao, Lei ^a   Chen, Xing Hua ^a  

^a Xinqiao Hospital   (China)

Author keywords

Hematopoietic microenvironment; Human umbilical cord blood derived cells; Interleukin 6; Multiple myeloma; Nuclear factor kappa B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; PROTEIN BCL 2; PROTEIN BCL XL; INTERLEUKIN 6 RECEPTOR; PROTEIN BCL X;

APOPTOSIS; ARTICLE; BONE MARROW BIOPSY; CELL PROLIFERATION; COCULTURE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; MESENCHYMAL STROMA CELL; MYELOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UMBILICAL CORD BLOOD; WESTERN BLOTTING; ACTIVE TRANSPORT; CELL CULTURE; CELL NUCLEUS; CONFOCAL MICROSCOPY; CYTOLOGY; FETUS BLOOD; GENETICS; METABOLISM; MULTIPLE MYELOMA; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL;

ACTIVE TRANSPORT, CELL NUCLEUS; APOPTOSIS; BCL-X PROTEIN; BLOTTING, WESTERN; CELL NUCLEUS; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; FETAL BLOOD; GENE EXPRESSION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MICROSCOPY, CONFOCAL; MULTIPLE MYELOMA; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, INTERLEUKIN-6; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROMAL CELLS;

EID: 84897882384     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/1607845413Y.0000000107     Document Type: Article

References (32)

1. Gao L, Chen X, Zhang X, Liu Y, Kong P, Peng X, et al. Human umbilical cord blood-derived stromal cell, a new resource of feeder layer to expand human umbilical cord blood CD34+ cells in vitro. Blood Cell Mol Dis 2006;36:322-8.
2. Méndez-Ferrer S, Frenette PS. Hematopoietic stem cell trafficking: regulated adhesion and attraction to bone marrow microenvironment. Ann N Y Acad Sci. 2007;11(16):392-413.
3. Feng Y, Wen J, Mike P, Choi DS, Eshoa C, Shi ZZ, et al. Bone marrow stromal cells from myeloma patients support the growth of myeloma stem cells. Stem Cells Dev. 2010;19(9):1289-96.
4. Basak GW, Srivastava AS, Malhotra R, Carrier E. Multiple myeloma bone marrow niche. Curr Pharm Biotechnol. 2009; 10(3):345-6.
5. Fowler JA, Edwardsa CM, Croucherb PI. Tumor-host cell interactions in the bone disease of myeloma. Bone 2011;48:121-8.
6. Hiruma Y, Honjo T, Jelinek DF, Windle JJ, Shin J, Roodman GD, et al. Increased signaling through p62 in the marrow microenvironment increases myeloma cell growth and osteoclast formation. Blood 2009;113(20):4894-902.
7. Zdzisińska B, Bojarska-Junak A, Walter-Croneck A, Kandefer-Szerszeń M. Dysregulation of the receptor activator of NFkappaB ligand and osteoprotegerin production influence the apoptosis of multiple myeloma patients' bone marrow stromal cells co-cultured with myeloma cells. Arch Immunol Ther Exp. (Warsz) 2010;58(2):153-63.
8. Markovina S, Callander NS, O'Connor SL, Xu G, Shi Y, Leith CP, et al. Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells. Mol Cancer. 2010;9:176-89.
9. Görgün G, Calabrese E, Soydan E, Hideshima T, Perrone G, Bandi M, et al. Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma. Blood 2010;116(17): 3227-37.
10. Zdzisiñska B, Roliñski J, Piersiak T, Kandefer-Szerszeñ M. A comparison of cytokine production in 2-dimensional and 3-dimensional cultures of bone marrow stromal cells of muliple myeloma patients in response to RPMI8226 myeloma cells. Folia Histochem Cytobiol. 2009;47(1):69-74.
11. Hideshima T, Chauhan D, Kiziltepe T, Ikeda H, Okawa Y, Podar K, et al. Biologic sequelae of IκB kinase (IKK) inhibition in multiple myeloma: therapeutic implications. Blood 2009; 113(21):5228-36.
12. Mahtouk K, Moreaux J, Hose D, Rème T, Meißner T, Jourdan M, et al. Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays. BMC Cancer 2010; 10:198.
13. Hideshima T, Podar K, Chauhan D, Anderson KC. Cytokines and signal transduction. Best Pract Res Clin Haematol. 2005; 18:509-24.
14. Azab AK, Runnels JM, Pitsillides C, Moreau A-S, Azab F, Leleu X, et al. CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. Blood 2009;113(18):4341-51.
15. Monika E, Roland M. 160 years of multiple myeloma: progress and challenges. Eur J Cancer 2006;42:1507-9.
16. Gao L, Chen X-H, Feng Y-M, Zhang X, Yu S-C, Gao L, et al. Human umbilical cord blood-derived stromal cells Multifaceted regulators of megakaryocytopoiesis. Cell Cycle 2010;9(7):1-12.
17. Feng Y, Chen X, Gao L. Hypothesis: human umbilical cord blood-derived stromal cells promote megakaryocytopoiesis through the influence of SDF-1 and PECAM-1. Cell Biochem Biophys. 2010;58:25-30.
18. Liu Y, Yi L, Zhang X, Gao L, Zhang C, Feng Y-M, et al. Cotransplantation of human umbilical cord blood-derived stromal cells enhances hematopoietic reconstitution and engraftment in irradiated BABL/c mice. Cancer Biol Ther. 2010;11(1): 1-11.
19. Liang X, Hao L, Chen X, Zhang X, Kong P, Peng X, et al. Effects of bone marrow stromal cells and umbilical cord blood-derived stromal cells on daunorubicin-resistant residual Jurkat cells. Transplant Proc. 2010;42:3767-72.
20. Zhang C, Chen X-H, Zhang X, Gao L, Kong PY, Peng XG, et al. Human umbilical cord blood-derived stromal cells, a new resource in the suppression of acute graft-versus-host disease in haploidentical stemcell transplantation in sublethally irradiated mice. J Biol Chem. 2011;286(15):13723-32.
21. Gao L, Zhang X, Gao L, Chen XH. Effect of stromal cells derived from different origins on proliferation and apoptosis of KM3 cells. Acta Acad Med Militaris Tertiae 2009;31(10): 879-82.
22. Pellegrino A, Ria R, Di Pietro G, Cirulli T, Surico G, Pennisi A. Bone marrow endothelial cells in multiple myeloma secrete CXC-chemokines that mediate interactions with plasma cells. Br J Haematol. 2005;129:248-56.
23. Feng Y, Ofek G, Soon Choi D, Wen J, Hu J, Zhao H, et al. Unique biomechanical interactions between myeloma cells and bone marrow stroma cells. Prog Biophys Mol Biol. 2010;103: 148-56.
24. Scheller J, Rose-John S. Interleukin-6 and its receptor: from bench to bedside. Med Microbiol Immunol. 2006;195: 173-83.
25. Jourdan M, Mahtouk K, Veyrune JL, Couderc G, Fiol G, Redal N, et al. Delineation of the roles of paracrine and autocrine interleukin-6 (IL-6) in myeloma cell lines in survival versus cell cycle. A possible model for the cooperation of myeloma cell growth factors. Eur Cytokine Netw. 2005;16(1):57-64.
26. Zdzisińska B, Bojarska-Junak A, Dmoszyńska A, Kandefer-Szerszeń M. Abnormal cytokine production by bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells. Arch Immunol Ther Exp. (Warsz) 2008;56(3):207-21.
27. Arnulf B, Lecourt S, Soulier J, Lacassagne MN, Crinquette A, Dessoly J, et al. Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma. Leukemia 2007;21:158-63.
28. Bisping G, Leo R, Wenning D, Dankbar B, Padro T, Kropff M, et al. Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma. Blood 2003;101:2775-83.
29. Kovacs E. How does interleukin-6 affect the membrane expressions of interleukin-6 receptor and gp130 and the proliferation of the human myeloma cell line OPM-2? Biomed Pharmacother. 2003;57:489-94.
30. Lasfar A, Wietzerbin J, Billard C. Differential regulation of interleukin-6 receptors by interleukin-6 and interferons in multiple myeloma cell lines. Eur J Immunol. 1994;24:124-30.
31. Thabard W, Collette M, Mellerin M-P, Puthier D, Barillé S, Bataille R, et al. IL-6 upregulates its own receptor on some human myeloma cell lines. Cytokine. 2001;14(6):352-6.
32. Conticelloa C, Giuffridab R, Adamob L, Anastasi G, Martinetti D, Salomonec E, et al. NF-κB localization in multiple myeloma plasma cells and mesenchymal cells. Leuk Res. 2011;35:52-60.